- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07518069
Genetische und biohumorale Faktoren bei Menière-Krankheit und ihre Korrelation mit Phänotypen (Menière09)
Genetik und biohumorale Faktoren bei Morbus Menière
Aim of this work was to assess the role of polymorphisms belonging to genes involved in the regulation of ionic homeostasis in Caucasian patients with Ménière Disease (MD) and compare results with a cohort of patients affected by vestibular migraine and a cohort of non vestibular subjects
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Ménière's Disease (MD) is an inner ear disorder characterized by episodic vertigo, fluctuating sensorineural hearing loss and aural fullness ; endolymphatic hydrops is commonly associated with the pathophysiology of the disorder, although current data support the hypothesis that hydrops is an epiphenomenon associated with different inner ear disorders. The frequency of familial cases has been estimated in the range between 5 and 15% and it has been hypothesized that the disorder may arise from the interplay of genetic and environmental factors. Different candidate genes have been studied, although to date genetic investigation produced no conclusive results .
Among others, considering the importance of ionic homeostasis in the inner ear for the maintenance of endocochlear potential, genetic of fluid and ionic homeostasis have been included. A mutation of KCNQ1 and KCNE1 channels, co-expressed in the inner ear and in the heart, leads to a severe sensorineural deafness and a collapse of the cochlear scala media as seen in Jervell and Lange-Nielsen syndrome.
The aim of this work was to assess the role of genetic polymorphisms located in genes involved in the regulation of ionic transport on an Italian population of patients with definite MD.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Roberto Carlo Teggi, MD
- Telefonnummer: +393921569410
- E-Mail: teggi.roberto@hsr.it
Studieren Sie die Kontaktsicherung
- Name: Laura Zagato, MD
- Telefonnummer: +393406133818
- E-Mail: zagato.laura@hsr.it
Studienorte
-
-
Italy
-
Milan, Italy, Italien, 20132
- Rekrutierung
- IRCCS San Raffaele
-
Kontakt:
- Roberto Carlo Teggi, MD
- Telefonnummer: +390226432628
- E-Mail: teggi.roberto@hsr.it
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Patients were included if they fulfilled criteria for definite unilateral MD according to the Barany Society; in subjects enrolled before 2015 a retrospective analysis of data confirmed Barany criteria
Beschreibung
Inclusion Criteria:
- Patients with definite Menière's Disease according to the criteria of the Barany Society
Exclusion Criteria:
- surgically treated before the examination or if they had undergone intratympanic therapy with steroids or gentamicin
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: CASE_CONTROL
- Zeitperspektiven: PROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Menière's Disease; vestibular migraine
Enrolled subjects should fulfil criteria for definite Menière's Disease (group MD) or definite Vestibular Migraine (VM) according to the ongoing criteria of the Barany Society. Moreover a cohort of non vertiginous subjects will be enrolled. A signed informed consent will be obtained by all subjects. A withdrawal for blood sample will be obtained to study genetic and biohumoral factors in the 3 groups |
A blood withdrawal will be obtained to assess
Andere Namen:
Genetics of ionic transporters and biohumoral factors related to Meniere's Disease and differences with vestibular migraine subjects |
|
Menière's Disease (MD)
To be included, subjects should fulfill definite diagnostic criteria for MD. A blood withdrawal will be obtained to assess genetic and biohumoral aspects |
A blood withdrawal will be obtained to assess
Andere Namen:
Genetics of ionic transporters and biohumoral factors related to Meniere's Disease and differences with vestibular migraine subjects |
|
Vestibular Migraine (VM)
To be included, subjects should fulfill definite diagnostic criteria for VM. A blood withdrawal will be obtained to assess genetic and biohumoral aspects |
A blood withdrawal will be obtained to assess
Andere Namen:
Genetics of ionic transporters and biohumoral factors related to Meniere's Disease and differences with vestibular migraine subjects |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Genetic of ionic transporters
Zeitfenster: From enrollment to the end of enrollment in december 2027
|
Genomic DNA of all cases and controls was extracted from venous blood by standard methods. 36 Single Nucleotide Polymorphisms (SNPs) were genotyped using TaqMan® OpenArray™ Genotyping System (Life Technologies, Foster City, CA). All DNA samples were loaded and amplified according to the manufacturer's instructions. |
From enrollment to the end of enrollment in december 2027
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Biohumoral factors specifically Interleukins, Endogenous Ouabain
Zeitfenster: From enrollment to the end of the study in july 2027
|
Values of interleukins and endogenous ouabain is evaluated in blood sample of patients and compared with values in blood samples of a control group and in patients with vestibular migraine |
From enrollment to the end of the study in july 2027
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Teggi R, Colombo B, Zagato L, Filippi M. Could ionic regulation disorders explain the overlap between meniere's disease and migraine? J Vestib Res. 2021;31(4):297-301. doi: 10.3233/VES-200788.
- Frejo L, Giegling I, Teggi R, Lopez-Escamez JA, Rujescu D. Genetics of vestibular disorders: pathophysiological insights. J Neurol. 2016 Apr;263 Suppl 1:S45-53. doi: 10.1007/s00415-015-7988-9. Epub 2016 Apr 15.
- Teggi R, Carpini SD, Zagato L. Endolymphatic hydrops and ionic transporters: genetic and biohumoral aspects. J Neurol. 2019 Sep;266(Suppl 1):47-51. doi: 10.1007/s00415-019-09399-6. Epub 2019 Jun 5.
- Teggi R, Zagato L, Delli Carpini S, Citterio L, Cassandro C, Albera R, Yang WY, Staessen JA, Bussi M, Manunta P, Lanzani C. Genetics of ion homeostasis in Meniere's Disease. Eur Arch Otorhinolaryngol. 2017 Feb;274(2):757-763. doi: 10.1007/s00405-016-4375-9. Epub 2016 Nov 11.
- Lopez-Escamez JA, Perez-Carpena P. Update on the pathophysiology, diagnosis and management of Meniere's disease. Curr Opin Otolaryngol Head Neck Surg. 2024 Oct 1;32(5):306-312. doi: 10.1097/MOO.0000000000001002. Epub 2024 Jul 22.
- Frejo L, Lopez-Escamez JA. Cytokines and Inflammation in Meniere Disease. Clin Exp Otorhinolaryngol. 2022 Feb;15(1):49-59. doi: 10.21053/ceo.2021.00920. Epub 2022 Feb 8.
- Teggi R, Battista RA, Di Berardino F, Familiari M, Cangiano I, Gatti O, Bussi M. Evaluation of a large cohort of adult patients with Meniere's disease: bedside and clinical history. Acta Otorhinolaryngol Ital. 2020 Dec;40(6):444-449. doi: 10.14639/0392-100X-N0776.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- GO/URC/ER/mm prot 762
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
A dataset with genetic data will be shared as a excel file
IPD-Sharing-Zeitrahmen
Initial data will be available in december
IPD-Sharing-Zugriffskriterien
Reviewers for the journal in which the work is submitted. On request, other researchers may access to data
Art der unterstützenden IPD-Freigabeinformationen
- CSR
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .